共 18 条
- [1] Correction to: Analysis of the first ten years of FDA’s rare pediatric disease priority review voucher program: designations, diseases, and drug development [J]. Orphanet Journal of Rare Diseases, 19
- [4] Suitability of expanding the priority review voucher into rare disease drug development [J]. EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (10): : 1001 - 1003
- [5] Is the priority review voucher program stimulating new drug development for tropical diseases? [J]. PLOS NEGLECTED TROPICAL DISEASES, 2018, 12 (08):
- [6] Experience With the Priority Review Voucher Program for Drug Development [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (16): : 1687 - 1688
- [10] Association of the Priority Review Voucher With Neglected Tropical Disease Drug and Vaccine Development [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 318 (04): : 388 - 389